These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 8790196

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Detecting recurrent or residual lung cancer with FDG-PET.
    Inoue T, Kim EE, Komaki R, Wong FC, Bassa P, Wong WH, Yang DJ, Endo K, Podoloff DA.
    J Nucl Med; 1995 May; 36(5):788-93. PubMed ID: 7738649
    [Abstract] [Full Text] [Related]

  • 3. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
    Garcia R, Kim EE, Wong FC, Korkmaz M, Wong WH, Yang DJ, Podoloff DA.
    J Nucl Med; 1996 Sep; 37(9):1476-9. PubMed ID: 8790197
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer.
    Lindholm P, Leskinen-Kallio S, Minn H, Bergman J, Haaparanta M, Lehikoinen P, Någren K, Ruotsalainen U, Teräs M, Joensuu H.
    J Nucl Med; 1993 Oct; 34(10):1711-6. PubMed ID: 8410288
    [Abstract] [Full Text] [Related]

  • 7. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
    Duhaylongsod FG, Lowe VJ, Patz EF, Vaughn AL, Coleman RE, Wolfe WG.
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
    [Abstract] [Full Text] [Related]

  • 8. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
    Tian M, Zhang H, Oriuchi N, Higuchi T, Endo K.
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1064-72. PubMed ID: 15014903
    [Abstract] [Full Text] [Related]

  • 9. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
    Nuñez R, Macapinlac HA, Yeung HW, Akhurst T, Cai S, Osman I, Gonen M, Riedel E, Scher HI, Larson SM.
    J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer.
    Bassa P, Kim EE, Inoue T, Wong FC, Korkmaz M, Yang DJ, Wong WH, Hicks KW, Buzdar AU, Podoloff DA.
    J Nucl Med; 1996 Jun; 37(6):931-8. PubMed ID: 8683314
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential diagnosis of lung tumor with positron emission tomography: a prospective study.
    Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, Iwata R, Ido T.
    J Nucl Med; 1990 Dec; 31(12):1927-32. PubMed ID: 2266388
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
    Kahn D, Follett KA, Bushnell DL, Nathan MA, Piper JG, Madsen M, Kirchner PT.
    AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
    [Abstract] [Full Text] [Related]

  • 18. Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET.
    Sasaki M, Kuwabara Y, Ichiya Y, Akashi Y, Yoshida T, Nakagawa M, Murayama S, Masuda K.
    J Nucl Med; 1999 Oct; 40(10):1595-601. PubMed ID: 10520697
    [Abstract] [Full Text] [Related]

  • 19. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma.
    Nieweg OE, Pruim J, van Ginkel RJ, Hoekstra HJ, Paans AM, Molenaar WM, Koops HS, Vaalburg W.
    J Nucl Med; 1996 Feb; 37(2):257-61. PubMed ID: 8667056
    [Abstract] [Full Text] [Related]

  • 20. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
    Patz EF, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC.
    Radiology; 1994 May; 191(2):379-82. PubMed ID: 8153309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.